Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. - Wikidata - awgldk - TriplyDB

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

http://www.wikidata.org/entity/Q36890872

about

Bone-cartilage crosstalk: a conversation for understanding osteoarthritis MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF.In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies.Procyanidins Mitigate Osteoarthritis Pathogenesis by, at Least in Part, Suppressing Vascular Endothelial Growth Factor Signaling TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis.Transcriptome-Wide Analyses of Human Neonatal Articular Cartilage and Human Mesenchymal Stem Cell-Derived Cartilage Provide a New Molecular Target for Evaluating Engineered Cartilage.Regenerative pharmacology: recent developments and future perspectives.lncRNAs: novel players in intervertebral disc degeneration and osteoarthritis.Wogonoside inhibits IL-1β induced catabolism and hypertrophy in mouse chondrocyte and ameliorates murine osteoarthritis.Vascular Endothelial Growth Factor in Cartilage Development and Osteoarthritis.Mixed cell therapy of bone marrow-derived mesenchymal stem cells and articular cartilage chondrocytes ameliorates osteoarthritis development.GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis.Integration of Gene Expression Profile Data to Screen and Verify Hub Genes Involved in Osteoarthritis Painful Understanding of VEGF

P2860

Q28078444-138E997C-11F7-4834-9EAD-18993531237E Q33804362-882B6235-CABD-4C22-BFF1-B22A8CD0688F Q33819576-1CE0A879-86A1-4E22-A377-F70E852DA824 Q36219819-F2F88EFB-0658-4525-922A-7DA68448C2D2 Q37745409-BFB6FE57-9A3C-4057-9256-8C85637F05EA Q38375725-2B127F8D-5840-4D0B-BDA4-A037DF4D4AAF Q38788701-A84BFD0F-EAC5-4DAC-BB8B-D1489C96F93E Q39012355-665E1E7C-4E8F-4C3A-B218-E19CC6AC0886 Q41980093-BE0BFFBD-0DFD-4399-8B30-8CA65BDB868E Q42375971-82504BE9-1396-4BB8-935B-67CB27939446 Q47788298-172FA6B6-7D6D-495B-85B5-383795F8788A Q55114300-0D39559F-6BC4-4A9B-8CB9-71063865504D Q58780624-0FEA4227-EBA4-4CE1-A744-FE11A88CC36B Q59128370-9D02CC9A-28D1-401D-B9B2-16DF6F70A909

P2860

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

http://www.wikidata.org/entity/Q36890872

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

@en

type

label

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

@en

prefLabel

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

@en

P1433

Q36890872-E5C6A0B3-8CEA-47CD-BA1F-D86A0430E938

P1476

Q36890872-759B8136-48E0-4FBC-ADAF-74147B32790E

P2093

Q36890872-03F42A69-9D88-4C65-8E31-88CC316B1FDA

Q36890872-21E81259-8163-476F-BFC4-82BB9CE269FC

Q36890872-5FD418F5-E1E9-4389-A5AD-9533578166DB

Q36890872-63E8F29F-FA2E-431E-8334-2F8DCC34BED5

Q36890872-DE1F3674-73F7-40A3-85A4-B40F65148E5C

Q36890872-FCA3EA40-757F-4A8C-AA6E-26D0E25C4472

P2860

Q36890872-025DFC99-14F6-4F65-8F5A-2FC328305D03

Q36890872-02974BC0-A408-4486-AA22-62435F2D2C8C

Q36890872-03629EA4-7A00-4889-8FF4-843D951EA42E

Q36890872-038479B3-BF71-4C33-B682-8C30F5BF7BA7

Q36890872-04CA326B-632A-437C-AA88-34DF49F2DD29

Q36890872-04E039DA-81B5-45B8-BA59-B75F65F048CD

Q36890872-05FEC5B1-C8F9-4DD4-85F9-07C4D71F0231

Q36890872-06D9B613-D7BE-4D52-A02B-536D68B5638F

Q36890872-08039E38-2BE1-4221-B4D5-1183B8A25376

Q36890872-0CFFC6CD-437E-449D-A303-12F2B9BD686A

P304

Q36890872-348F1AD8-6AA3-4679-A15B-E8AA504DD8BC

P31

Q36890872-38a8e58e-8c42-4575-a7ba-31be97dd3b76

Q36890872-C73DB621-F8A2-4D49-95DE-58DFA0A04789

P356

Q36890872-29A0D91B-5D17-472C-8823-FB9E4C04D3F9

P433

Q36890872-5E4BA071-887F-4886-9CB2-AC4AC5B9A1F9

P478

Q36890872-D149A500-98A3-4A07-B6B5-001FCE5564EA

P577

Q36890872-77E52E97-E619-4940-BAE2-914874698EEF

P698

Q36890872-0D2A6E09-1BA0-42B2-B4E4-94B7423BD398

P932

Q36890872-2BCF8CB1-692A-4F0E-AE5C-BE72E178BFF8

P356

P1433

Journal of Bone and Mineral Research

P1476

Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

@en

P2093

Bjorn R Olsen

http://www.w3.org/2001/XMLSchema#string

Brett R Levine

http://www.w3.org/2001/XMLSchema#string

Di Chen

http://www.w3.org/2001/XMLSchema#string

Hee-Jeong Im

http://www.w3.org/2001/XMLSchema#string

John L Hamilton

http://www.w3.org/2001/XMLSchema#string

Masashi Nagao

http://www.w3.org/2001/XMLSchema#string

P2860

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1

The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis

Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis

Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management

The biology of VEGF and its receptors

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation

P304

911-924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.2828

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27163679

http://www.w3.org/2001/XMLSchema#string

P932

4863467

http://www.w3.org/2001/XMLSchema#string